NVS - NOVARTIS AG

161.01
-4.140   -2.571%

Share volume: 4,260,169
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.31%

PREVIOUS CLOSE
CHG
CHG%
$165.15
-4.14
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
60%
Profitability 43%
Dept financing 38%
Liquidity 43%
Performance 87%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-3.51%
1 Month
2.93%
3 Months
23.69%
6 Months
25.10%
1 Year
42.65%
2 Year
56.87%
Key data
Stock price
$161.01
P/E Ratio 
16.66
DAY RANGE
$158.95 - $161.39
EPS 
$5.76
52 WEEK RANGE
$97.72 - $170.46
52 WEEK CHANGE
$39.32
MARKET CAP 
198.905 B
YIELD 
3.88%
SHARES OUTSTANDING 
2.190 B
DIVIDEND
$3.8695
EX-DIVIDEND DATE
03-12-2025
NEXT EARNINGS DATE
07-17-2025
BETA 
0.27
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,362,649
AVERAGE 30 VOLUME 
$2,981,250
Company detail
CEO: Vasant Narasimhan
Region: US
Website: novartis.com
Employees: 101,700
IPO year: 1996
Issue type: American Depository Receipt (ADR’s)
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Novartis AG researches, develops, manufactures, and markets healthcare products. The company operates through two segments, Innovative Medicines and Sandoz. Sandoz provides finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals.

Recent news